Onco-nephrology: Core Curriculum 2015.

From Zablocki VAMC, Medical College of Wisconsin, Milwaukee, WI; CHU Université de Liège, Liège, Belgium; Hôpital de la Salpetrière, Paris, France; and Katholieke Universiteit Leuven, Leuven, Belgium. Received January 20, 2015. Accepted in revised form April 6, 2015. Originally published online June 6, 2015. Current affiliation: Baltimore VAMC and the University of Maryland School of Medicine, Baltimore, MD. Address correspondence to Eric P. Cohen, MD, Baltimore VAMC, 10 N Greene St, Baltimore, MD, 21201. E-mail: eric. [email protected] Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use. 0272-6386 http://dx.doi.org/10.1053/j.ajkd.2015.04.042 The overlap between oncology and nephrology is an area of growing importance. A major reason for this is that less than half the patients with cancer were long-term survivors years ago, whereas now more than two-thirds will live 5 years or longer. Late effects of cancer treatment include nephrotoxicity and are part of current clinical practice. In addition, cancer is now a known feature of chronic kidney disease (CKD), with increased risk in patients receiving dialysis or with a functioning kidney transplant, as well as those with earlier stages of the disease. Therefore, oncologists will refer patients to nephrologists, and nephrologists will need to consult oncologists. This Core Curriculum addresses the key issues at this challenging clinical interface.